Details Emerge About China's Investigation of GlaxoSmithKline (GSK)
7/9/2013 2:37:54 PM
Get the latest biotech news where you want it. Sign up for the free
GenePool newsletter today!
by Richard Daverman, PhD
July 9, 2013 -- About a week after China officials raided three major GlaxoSmithKline offices in China, looking for evidence of “economic crimes,” more of the story has been revealed. It is alleged that GSK’s sales force in Chengdu hatched a scheme to pay doctors to prescribe Botox, the wrinkle treatment, offering payments up to $490. Apparently, China authorities have proof that GSK’s salespeople talked about a pay-per-prescription plan. However, so far, they do not have evidence that any doctors were actually paid. More details....
Stock Symbol: (NYSE: GSK)
Help employers find you! Check out all the jobs and post your resume.
comments powered by